规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | MRTX0902 is a potent, orally active SOS1 inhibitor with an IC50 of 46 nM, as described in WO2021127429A1[1]. |
体内研究 | MRTX0902 (25, 50 mg/kg; orally; twice daily; 25 days) exhibits an anti-tumor effect, leading to tumor regression in a mouse model[1]. MRTX0902, administered intravenously (1-3 mg/kg) or orally (10-30 mg/kg) as a single dose, achieves good brain penetration, low clearance, and high bioavailability[1]. Pharmacokinetic Parameters for MRTX0902 across Species[1]. |
体外研究 | MRTX0902 (1 μM; 0, 2, 4, 8, 15, and 30 minutes) demonstrates a moderate intrinsic clearance (Clint) value of 195 mL/min/kg in human liver microsomes and low lipophilicity, with a cLogP of 3.4[1]. MRTX0902 shows high selectivity for SOS1 (Ki=2 nM), with much lower affinity for SOS2 and EGFR (both Ki values >10,000 nM), and inhibits MKN1 cells with an IC50 of 29 nM[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.57mL 0.51mL 0.26mL |
12.87mL 2.57mL 1.29mL |
25.74mL 5.15mL 2.57mL |
CAS号 | 2654743-22-1 |
分子式 | C22H24N6O |
分子量 | 388.466 |
别名 | |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Sealed in dry,2-8°C |
溶解度 |
DMSO: 12 mg/mL(30.89 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |